BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 36928678)

  • 1. Restoration of mitochondrial function through activation of hypomodified tRNAs with pathogenic mutations associated with mitochondrial diseases.
    Tomoda E; Nagao A; Shirai Y; Asano K; Suzuki T; Battersby BJ; Suzuki T
    Nucleic Acids Res; 2023 Aug; 51(14):7563-7579. PubMed ID: 36928678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human mitochondrial diseases caused by lack of taurine modification in mitochondrial tRNAs.
    Suzuki T; Nagao A; Suzuki T
    Wiley Interdiscip Rev RNA; 2011; 2(3):376-86. PubMed ID: 21957023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial haplotype mutation alleviates respiratory defect of MELAS by restoring taurine modification in tRNA with 3243A > G mutation.
    Ueda S; Yagi M; Tomoda E; Matsumoto S; Ueyanagi Y; Do Y; Setoyama D; Matsushima Y; Nagao A; Suzuki T; Ide T; Mori Y; Oyama N; Kang D; Uchiumi T
    Nucleic Acids Res; 2023 Aug; 51(14):7480-7495. PubMed ID: 37439353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased ATP synthesis is phenotypically expressed during increased energy demand in fibroblasts containing mitochondrial tRNA mutations.
    James AM; Sheard PW; Wei YH; Murphy MP
    Eur J Biochem; 1999 Jan; 259(1-2):462-9. PubMed ID: 9914528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations.
    James AM; Wei YH; Pang CY; Murphy MP
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):401-7. PubMed ID: 8809026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The A to G transition at nt 3243 of the mitochondrial tRNALeu(UUR) may cause an MERRF syndrome.
    Fabrizi GM; Cardaioli E; Grieco GS; Cavallaro T; Malandrini A; Manneschi L; Dotti MT; Federico A; Guazzi G
    J Neurol Neurosurg Psychiatry; 1996 Jul; 61(1):47-51. PubMed ID: 8676159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defect in modification at the anticodon wobble nucleotide of mitochondrial tRNA(Lys) with the MERRF encephalomyopathy pathogenic mutation.
    Yasukawa T; Suzuki T; Ishii N; Ueda T; Ohta S; Watanabe K
    FEBS Lett; 2000 Feb; 467(2-3):175-8. PubMed ID: 10675533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease.
    Kirino Y; Yasukawa T; Ohta S; Akira S; Ishihara K; Watanabe K; Suzuki T
    Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15070-5. PubMed ID: 15477592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human mitochondrial diseases associated with tRNA wobble modification deficiency.
    Kirino Y; Suzuki T
    RNA Biol; 2005 Apr; 2(2):41-4. PubMed ID: 17132941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Search for differences in post-transcriptional modification patterns of mitochondrial DNA-encoded wild-type and mutant human tRNALys and tRNALeu(UUR).
    Helm M; Florentz C; Chomyn A; Attardi G
    Nucleic Acids Res; 1999 Feb; 27(3):756-63. PubMed ID: 9889270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sporadic MERRF/MELAS overlap syndrome associated with the 3243 tRNA(Leu(UUR)) mutation of mitochondrial DNA.
    Campos Y; Martin MA; Lorenzo G; Aparicio M; Cabello A; Arenas J
    Muscle Nerve; 1996 Feb; 19(2):187-90. PubMed ID: 8559168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of taurine in the pathologies of MELAS and MERRF.
    Schaffer SW; Jong CJ; Ito T; Azuma J
    Amino Acids; 2014 Jan; 46(1):47-56. PubMed ID: 23179085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of known base substitution mutations in human mitochondrial DNA of MERRF and MELAS by biochip technology.
    Du W; Li W; Chen G; Cao H; Tang H; Tang X; Jin Q; Sun Z; Zhao H; Zhou W; He S; Lv Y; Zhao J; Zhang X
    Biosens Bioelectron; 2009 Apr; 24(8):2371-6. PubMed ID: 19155171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MERRF/MELAS overlap syndrome due to the m.3291T>C mutation.
    Liu K; Zhao H; Ji K; Yan C
    Metab Brain Dis; 2014 Mar; 29(1):139-44. PubMed ID: 24338029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histochemical and molecular genetic study of MELAS and MERRF in Korean patients.
    Kim DS; Jung DS; Park KH; Kim IJ; Kim CM; Lee WH; Rho SK
    J Korean Med Sci; 2002 Feb; 17(1):103-12. PubMed ID: 11850598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear DNA-encoded tRNAs targeted into mitochondria can rescue a mitochondrial DNA mutation associated with the MERRF syndrome in cultured human cells.
    Kolesnikova OA; Entelis NS; Jacquin-Becker C; Goltzene F; Chrzanowska-Lightowlers ZM; Lightowlers RN; Martin RP; Tarassov I
    Hum Mol Genet; 2004 Oct; 13(20):2519-34. PubMed ID: 15317755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wobble modification defect in tRNA disturbs codon-anticodon interaction in a mitochondrial disease.
    Yasukawa T; Suzuki T; Ishii N; Ohta S; Watanabe K
    EMBO J; 2001 Sep; 20(17):4794-802. PubMed ID: 11532943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MERRF/MELAS overlap syndrome: a double pathogenic mutation in mitochondrial tRNA genes.
    Nakamura M; Yabe I; Sudo A; Hosoki K; Yaguchi H; Saitoh S; Sasaki H
    J Med Genet; 2010 Oct; 47(10):659-64. PubMed ID: 20610441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquisition of the wobble modification in mitochondrial tRNALeu(CUN) bearing the G12300A mutation suppresses the MELAS molecular defect.
    Kirino Y; Yasukawa T; Marjavaara SK; Jacobs HT; Holt IJ; Watanabe K; Suzuki T
    Hum Mol Genet; 2006 Mar; 15(6):897-904. PubMed ID: 16446307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteine Supplementation May be Beneficial in a Subgroup of Mitochondrial Translation Deficiencies.
    Bartsakoulia M; Mϋller JS; Gomez-Duran A; Yu-Wai-Man P; Boczonadi V; Horvath R
    J Neuromuscul Dis; 2016 Aug; 3(3):363-379. PubMed ID: 27854233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.